Futurera Pharma-Tech Private Limited - Due diligence report

A 360° intelligence report on Futurera Pharma-Tech Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2018-11-28 Bangalore, Karnataka Active Unlisted Active Compliant
Share
FP Futurera Pharma-Tech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Futurera Pharma-Tech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
61/100
Trust Score
Moderate

Futurera Pharma-Tech Private Limited is assessed as Moderate with a Trust Score of 61/100. Futurera Pharma-Tech Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 19 Jul 2026 from the latest processed filings. Futurera Pharma-Tech Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
RAJACHANDRA AKELLA VISWANADH 01234567 Director 01/04/2018 6 yrs Approved
CHANDRA SEKHAR AYYALASOMAYAJULA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 55
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Operating for 7 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view35/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 6 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
01 Aug 2023
Director appointed
RAJACHANDRA AKELLA VISWANADH (Director)
Director ceased
NISTALA SRIRAMAMURTY
28 Nov 2018
Incorporated
Registered with Roc Bangalore
Director appointed
CHANDRA SEKHAR AYYALASOMAYAJULA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 2 financial year(s).
Net profit margin moved from 24% to 0.86.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Abacus Brands Private Limited U52100UP2022PTC160442 Lucknow, Uttar Pradesh, India
Vardhan Ayurvedic & Herbals Medicines Private Limited U24232CH2010PTC032662 Chandigarh, Chandigarh, India
E Machines India Private Limited U29220DL2011PTC213465 New Delhi, Delhi, India
Au Naturel Beauty Private Limited U24110WB2021PTC248494 Kolkata, West Bengal, India
Dsm Auto Services Private Limited U51109WB2008PTC128053 Kolkata, West Bengal, India
Touchstone Corporate Services Private Limited U74140KA2009PTC049561 Bangalore, Karnataka, India
Herb Ayurveda Multitrade Private Limited U52590DL2015PTC281523 New Delhi, Delhi, India
Shail Green Energy Power Private Limited U40100DL2016PTC289509 Pitampura, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Futurera Pharma-Tech Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Futurera Pharma-Tech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 45/100, margin trends, ownership structure and peer set for Futurera Pharma-Tech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Futurera Pharma-Tech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Futurera Pharma-Tech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Futurera Pharma-Tech Private Limited an active company?

Futurera Pharma-Tech Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Futurera Pharma-Tech Private Limited financially healthy?

Futurera Pharma-Tech Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Futurera Pharma-Tech Private Limited?

Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Futurera Pharma-Tech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Futurera Pharma-Tech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Futurera Pharma-Tech Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Futurera Pharma-Tech Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.